However, our results need to be further verified before they can be used to assist the clinical treatment of patients with BC, such as determining whether it is appropriate to apply PD-L1 blockade therapy and to finally achieve the purpose of predicting and improving the prognosis of patients with BC. The gene discussed is CD274; the disease is breast cancer.